Life  

UNAUDITED GROUP RESULTS

FOR THE PERIOD ENDED 31 MARCH 2018,
SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE, FURTHER CAUTIONARY AND TRADING STATEMENT

Downloads

PDF DOWNLOADS

EXCEL DOWNLOADS

VIEW WEBCAST

Highlights

Revenue
 
+17.5%
to R11.3 billion
Cash generated from operations
+  37.3%
to R2.7 billion
Normalised EBITDA
 
+10.5%
to R2.7 billion

Interim dividend of 38 cents per share
 
+8.6%
Headline earnings per share increased to 53.7 cents
+116.5%

Financials

Commentary

OVERVIEW

The Group’s results for the six months ended 31 March 2018 reflect a good performance from the southern African operations with a return to positive paid patient day (PPD) growth, an excellent turnaround in the Scanmed S.A. (Scanmed) operations in Poland and a solid performance from Alliance Medical Group Limited (Alliance Medical) in a changing UK environment.